{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:41:41Z","timestamp":1774716101408,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ghir.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T13:37:41Z","timestamp":1520861861000},"page":"71-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred"],"prefix":"10.1016","volume":"41","author":[{"given":"Cindi G.","family":"Marinho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia M.","family":"Mermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Junior","given":"Jo\u00e3o A.","family":"Assirati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla R.P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elenilde G.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngela C.G.B.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia S.","family":"Barros-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayra P.","family":"Damascena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarine T.","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayrton C.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel H.","family":"Aguiar-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2018.03.004_bb0005","series-title":"The History of Clinical Endocrinology","first-page":"337","article-title":"Present trends and outlook for the future \u2013 part II","author":"Medvei","year":"1993"},{"key":"10.1016\/j.ghir.2018.03.004_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2017.02.004","article-title":"Controversies in the risk of neoplasia in GH deficiency","volume":"31","author":"Pekic","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0020","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1210\/jcem.86.7.7634","article-title":"Clinical perspective: acromegaly and cancer: a problem","volume":"86","author":"Jenkins","year":"2001","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr. Relat. Cancer."},{"key":"10.1016\/j.ghir.2018.03.004_bb0030","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2018.03.004_bb0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/gerona\/glp017","article-title":"Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor\/binding protein knockout mice","volume":"64","author":"Ikeno","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ghir.2018.03.004_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.ghir.2018.03.004_bb0045","doi-asserted-by":"crossref","first-page":"21579","DOI":"10.18632\/oncotarget.15375","article-title":"Targeting growth hormone receptor in human melanoma cells attenuate tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways","volume":"13","author":"Basu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ghir.2018.03.004_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12672-017-0292-7","article-title":"Growth hormone receptor knockdown sensitizes human melanoma cells to chemotherapy by attenuating expression of ABC drug efflux pumps","volume":"8","author":"Basu","year":"2017","journal-title":"Horm. Canc."},{"issue":"1","key":"10.1016\/j.ghir.2018.03.004_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2013.10.023","article-title":"Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment","volume":"441","author":"Sustarsic","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2018.03.004_bb0060","first-page":"3279","article-title":"Molecular basis of familial growth hormone deficiency","volume":"42","author":"P\u00e9rez Jurado","year":"1994","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2018.03.004_bb0065","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/EJE-16-1047","article-title":"The multiple facets of GHRH\/GH\/IGF-I axis: lessons from lifetime, untreated, isolated, GH deficiency due to GHRH receptor gene mutation","volume":"177","author":"Aguiar-Oliveira","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2018.03.004_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/molecules22030356","article-title":"Impact of age and insulin-like growth factor-1 on DNA damage responses in UV-irradiated human skin","volume":"22","author":"Kemp","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ghir.2018.03.004_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/exd.12637","article-title":"Insulin-like growth factor-I and UVB photoprotection in human keratinocytes","volume":"24","author":"Fernandez","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ghir.2018.03.004_bb0080","first-page":"4118","article-title":"Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-Releasing Hormone Receptor on Insulin-like Growth Factors (IGFs), IGF-Binding Proteins, and ternary complex formation throughout life","volume":"84","author":"Aguiar-Oliveira","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0085","first-page":"917","article-title":"Familial isolated growth hormone deficiency due to a novel mutation in the growth hormone releasing hormone receptor","volume":"84","author":"Salvatori","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ghir.2018.03.004_bb0095","series-title":"(Org.). Tempo e Clima no Brasil","author":"Cavalcanti","year":"2009"},{"key":"10.1016\/j.ghir.2018.03.004_bb0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clindermatol.2006.04.011","article-title":"Skin manifestations in acromegaly","volume":"24","author":"Ben-Shlomo","year":"2006","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ghir.2018.03.004_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11154-016-9378-8","article-title":"Skin manifestations of growth hormone-induced diseases","volume":"17","author":"Kanaka-Gantenbein","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"Suppl1","key":"10.1016\/j.ghir.2018.03.004_bb0115","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ghir.2018.03.004_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11864-017-0496-7","article-title":"Recent advances in the classification and treatment of Ependymomas","volume":"18","author":"Leeper","year":"2017","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"9","key":"10.1016\/j.ghir.2018.03.004_bb0125","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2018.03.004_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.2008.03391.x","article-title":"GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence","volume":"70","author":"Arnold","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.ghir.2018.03.004_bb0135","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2018.03.004_bb0140","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2018.03.004_bb0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(87)90355-2","article-title":"Does growth hormone cause relapse of brain tumors? PlumXMetrics","volume":"329","author":"Clayton","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2018.03.004_bb0150","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-015-2269-z","article-title":"Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analyses","volume":"36","author":"Shen","year":"2015","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.ghir.2018.03.004_bb0155","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1210\/jc.2017-00214","article-title":"Mortality in children receiving growth hormone treatment of growth disorders: data from the genetics and neuroendocrinology of Short Stature International Study","volume":"102","author":"Quigley","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.03.004_bb0160","series-title":"Laron Syndrome \u2013 From Man to Mouse: Lessons from clinical and experimental experience","author":"Laron","year":"2011"},{"key":"10.1016\/j.ghir.2018.03.004_bb0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jc.2015-1678","article-title":"Absent GH receptor deficiency with obesity and enhanced insulin sensitivity","volume":"100","author":"Guevara Aguirre","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637418300327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637418300327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:42Z","timestamp":1761087102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637418300327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"alternative-id":["S1096637418300327"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2018.03.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}